[{"address1": "Clarence Thomas Building", "address2": "P.O. Box 4649 Road Town", "city": "Tortola", "zip": "VG1110", "country": "British Virgin Islands", "phone": "203 221 7378", "website": "https://www.portagebiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; and PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors. The company also develops PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials. Portage Biotech Inc. is based in Tortola, British Virgin Islands.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Robert A. Kramer Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "totalPay": 185891, "exercisedValue": 0, "unexercisedValue": 128769}, {"maxAge": 1, "name": "Mr. Alexander  Pickett", "title": "CEO & Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eun-Jae  Park CPA", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Adam  Melero", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Molloy", "title": "Chief Executive Officer of Cyncado Therapeutics Inc.", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.76, "open": 10.72, "dayLow": 9.88, "dayHigh": 10.94, "regularMarketPreviousClose": 10.76, "regularMarketOpen": 10.72, "regularMarketDayLow": 9.88, "regularMarketDayHigh": 10.94, "payoutRatio": 0.0, "beta": 0.972, "forwardPE": -19.750002, "volume": 122057, "regularMarketVolume": 122057, "averageVolume": 1362745, "averageVolume10days": 1657500, "averageDailyVolume10Day": 1657500, "bid": 9.88, "ask": 10.4, "bidSize": 1, "askSize": 1, "marketCap": 16898772, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 23.01, "fiftyDayAverage": 6.27984, "twoHundredDayAverage": 5.159945, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9074276, "profitMargins": 0.0, "floatShares": 551729, "sharesOutstanding": 1645450, "sharesShort": 131854, "sharesShortPriorMonth": 13819, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0801, "heldPercentInsiders": 0.51378, "heldPercentInstitutions": 0.06196, "shortRatio": 0.04, "shortPercentOfFloat": 0.1012, "impliedSharesOutstanding": 1645450, "bookValue": 1.252, "priceToBook": 8.202876, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -67278000, "trailingEps": -68.17, "forwardEps": -0.52, "lastSplitFactor": "1:20", "lastSplitDate": 1723680000, "enterpriseToEbitda": -0.775, "52WeekChange": 0.6781045, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 10.27, "recommendationKey": "none", "totalCash": 1764000, "totalCashPerShare": 1.574, "ebitda": -11715000, "totalDebt": 28000, "quickRatio": 2.674, "currentRatio": 3.077, "debtToEquity": 4.029, "returnOnAssets": -0.15454, "returnOnEquity": -1.98892, "freeCashflow": -6307750, "operatingCashflow": -9798000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PRTG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746230068, "regularMarketTime": 1746216000, "shortName": "Portage Biotech Inc.", "longName": "Portage Biotech Inc.", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_233586353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.553901, "regularMarketPrice": 10.27, "fiftyDayAverageChange": 3.9901605, "fiftyDayAverageChangePercent": 0.63539207, "twoHundredDayAverageChange": 5.1100554, "twoHundredDayAverageChangePercent": 0.99033135, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-25", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1009981800000, "postMarketChangePercent": -1.16846, "postMarketPrice": 10.15, "postMarketChange": -0.120001, "regularMarketChange": -0.48999977, "regularMarketDayRange": "9.88 - 10.94", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1362745, "fiftyTwoWeekLowChange": 8.17, "fiftyTwoWeekLowChangePercent": 3.8904765, "fiftyTwoWeekRange": "2.1 - 23.01", "fiftyTwoWeekHighChange": -12.74, "fiftyTwoWeekHighChangePercent": -0.5536723, "fiftyTwoWeekChangePercent": 67.810455, "dividendDate": 1591228800, "earningsTimestampStart": 1746788340, "earningsTimestampEnd": 1747224000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -68.17, "epsForward": -0.52, "displayName": "Portage Biotech", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]